Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States

: | Nasdaq: OREX

Similar to: Skystar Bio-Pharmaceutical Co., Ipsen SA, Mast Therapeutics, Inc.

Orexigen Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of pharmaceutical product candidates for the treatment of obesity. Its product candidate, NB32, is an investigational medicine for weight loss and the maintenance of weight loss; and Empatic used for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

News & Analysis

You may also be interested in: